75 related articles for article (PubMed ID: 7811532)
21. Cationic nanoglycolipidic particles as vector and adjuvant for the study of the immunogenicity of SIV Nef protein.
Ben Haij N; Mzoughi O; Planès R; Bahraoui E
Int J Pharm; 2012 Feb; 423(1):116-23. PubMed ID: 21762763
[TBL] [Abstract][Full Text] [Related]
22. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
23. Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine.
Hone DM; Lewis GK; Beier M; Harris A; McDaniels T; Fouts TR
Dev Biol Stand; 1994; 82():159-62. PubMed ID: 7958470
[TBL] [Abstract][Full Text] [Related]
24. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella.
Whittle BL; Lee E; Weir RC; Verma NK
J Med Microbiol; 1997 Feb; 46(2):129-38. PubMed ID: 9060872
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
26. [Protective efficacy of co-immunization with Sj26 DNA and recombinant protein vaccine against Schistosoma japonicum in mice].
Yu GQ; Liu WQ; Lei JH; Mo HM; Chen YL; Li YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):51-5. PubMed ID: 16866145
[TBL] [Abstract][Full Text] [Related]
27. Design and in vivo immunogenicity of a polyvalent vaccine based on SIVmac regulatory genes.
Hel Z; Tryniszewska E; Tsai WP; Johnson JM; Harrod R; Fullen J; Kalyanaraman VS; Altman JD; McNally J; Karpova T; Felber BK; Tartaglia J; Franchini G
DNA Cell Biol; 2002 Sep; 21(9):619-26. PubMed ID: 12396604
[TBL] [Abstract][Full Text] [Related]
28. Towards new mycobacterial vaccines.
Gicquel B
Dev Biol Stand; 1994; 82():171-8. PubMed ID: 7958472
[TBL] [Abstract][Full Text] [Related]
29. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.
Braga CJ; Massis LM; Sbrogio-Almeida ME; Alencar BC; Bargieri DY; Boscardin SB; Rodrigues MM; Ferreira LC
Vaccine; 2010 Feb; 28(5):1373-82. PubMed ID: 19932669
[TBL] [Abstract][Full Text] [Related]
30. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines.
Vindurampulle CJ; Attridge SR
Infect Immun; 2003 Jan; 71(1):287-97. PubMed ID: 12496178
[TBL] [Abstract][Full Text] [Related]
31. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
32. Protection of monkeys vaccinated with vpr- and/or nef-defective simian immunodeficiency virus strain mac/human immunodeficiency virus type 1 chimeric viruses: a potential candidate live-attenuated human AIDS vaccine.
Igarashi T; Ami Y; Yamamoto H; Shibata R; Kuwata T; Mukai R; Shinohara K; Komatsu T; Adachi A; Hayami M
J Gen Virol; 1997 May; 78 ( Pt 5)():985-9. PubMed ID: 9152414
[TBL] [Abstract][Full Text] [Related]
33. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
[TBL] [Abstract][Full Text] [Related]
34. The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience.
Whittle BL; Verma NK
Vaccine; 1997 Nov; 15(16):1737-40. PubMed ID: 9364676
[TBL] [Abstract][Full Text] [Related]
35. Potent, persistent cellular immune responses elicited by sequential immunization of rhesus macaques with Ad5 host range mutant recombinants encoding SIV Rev and SIV Nef.
Patterson LJ; Malkevitch N; Zhao J; Peng B; Robert-Guroff M
DNA Cell Biol; 2002 Sep; 21(9):627-35. PubMed ID: 12396605
[TBL] [Abstract][Full Text] [Related]
36. Comparison of phage pIII, pVIII and GST as carrier proteins for peptide immunisation in Balb/c mice.
Yip YL; Smith G; Ward RL
Immunol Lett; 2001 Dec; 79(3):197-202. PubMed ID: 11600198
[TBL] [Abstract][Full Text] [Related]
37. Production and characterization of a monoclonal antibody against Schistosoma japonicum glutathione S-transferase.
Campbell MJ; McFall P; Niederhuber JE
J Immunol Methods; 1995 Dec; 188(1):73-8. PubMed ID: 8551040
[TBL] [Abstract][Full Text] [Related]
38. Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine.
Newton SM; Joys TM; Anderson SA; Kennedy RC; Hovi ME; Stocker BA
Res Microbiol; 1995; 146(3):203-16. PubMed ID: 7569315
[TBL] [Abstract][Full Text] [Related]
39. An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains.
Link C; Ebensen T; Ständner L; Déjosez M; Reinhard E; Rharbaoui F; Guzmán CA
Microbes Infect; 2006 Jul; 8(8):2262-9. PubMed ID: 16793312
[TBL] [Abstract][Full Text] [Related]
40. The influence of adjuvant on humoral responses to glutathione-S-transferase fusion proteins.
Varley CA; Dunne DW; Havercroft JC
Parasite Immunol; 1992 Sep; 14(5):557-62. PubMed ID: 1437243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
